Market research
BIOFILCHEM.NSE Biofil Chemicals and Pharmaceuticals Limited
NSE INR Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 492M
- P/E ratio
- 17.7
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.57
Community
Investor discussion
1 comment
Sign in to join the BIOFILCHEM.NSE discussion.
5 years, 4 months ago
Biofil Chemicals and Pharmaceuticals Limited is currently in a long term downtrend where the price is trading 39.5% below its 200 day moving average.
From a valuation standpoint, the stock is 1.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.7.
Biofil Chemicals and Pharmaceuticals Limited's total revenue sank by 75.0% to $32M since the same quarter in the previous year.
Its net income has increased by 123.4% to $5M since the same quarter in the previous year.
Based on the above factors, Biofil Chemicals and Pharmaceuticals Limited gets an overall score of 2/5.